Pharma Collaboration Proven pharma collaboration track record with Lilly and Merck and ongoing NIH partnerships; provides a compelling case for co-funding translational research programs, biomarker studies, and investigator-initiated trials through LuMind IDSC’s research networks.

Community Recruitment Access to a large online Down syndrome community and extensive caregiver networks, plus regional events, offers a robust channel for patient recruitment, trial awareness campaigns, and sponsor-branded education initiatives that align with family needs.

NDSS Expansion Strategic expansion through the NDSS merger broadens reach and credibility, unlocking new joint sponsorships, grant opportunities, and cross-promoted research and education programs that can accelerate trial enrollment and public awareness.

Translational Research Experience funding and enabling translational science via the DS-CTN and target areas like Alzheimer’s onset and sleep apnea, signaling opportunities to partner on specific biomarker projects, imaging studies, and access to patient cohorts and data resources.

Education Platform Active education and outreach platform with webinars, focus groups, caregiver resources, and a digital footprint creates sponsorship opportunities for medical affairs communications, education campaigns, and patient insights studies.